{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -1.8181801, "regularMarketPrice": 3.24, "exchange": "NCM", "shortName": "Longeveron Inc.", "longName": "Longeveron Inc.", "messageBoardId": "finmb_410711455", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 0.975, "fiftyDayAverage": 2.9233, "fiftyDayAverageChange": 0.31669998, "fiftyDayAverageChangePercent": 0.10833646, "twoHundredDayAverage": 3.78773, "twoHundredDayAverageChange": -0.54772997, "twoHundredDayAverageChangePercent": -0.1446064, "marketCap": 70478424, "forwardPE": -4.32, "priceToBook": 3.323077, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-12", "prevName": "Longeveron LLC", "nameChangeDate": "2023-05-15", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1620989940, "earningsTimestampStart": 1620989940, "earningsTimestampEnd": 1620989940, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.87, "epsForward": -0.75, "epsCurrentYear": -0.95, "priceEpsCurrentYear": -3.4105263, "sharesOutstanding": 6179860, "firstTradeDateMilliseconds": 1613140200000, "priceHint": 4, "preMarketChange": 0.0, "preMarketChangePercent": 0.0, "preMarketTime": 1684227359, "preMarketPrice": 3.24, "regularMarketChange": -0.059999943, "regularMarketTime": 1684180804, "regularMarketDayHigh": 3.38, "regularMarketDayRange": "3.12 - 3.38", "regularMarketDayLow": 3.12, "regularMarketVolume": 113844, "regularMarketPreviousClose": 3.3, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 9, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 3.27, "averageDailyVolume3Month": 160318, "averageDailyVolume10Day": 858210, "fiftyTwoWeekLowChange": 0.74, "fiftyTwoWeekLowChangePercent": 0.296, "fiftyTwoWeekRange": "2.5 - 9.34", "fiftyTwoWeekHighChange": -6.1000004, "fiftyTwoWeekHighChangePercent": -0.65310496, "fiftyTwoWeekLow": 2.5, "fiftyTwoWeekHigh": 9.34, "marketState": "PRE", "displayName": "Longeveron", "symbol": "LGVN"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Life Science & Technology Park", "address2": "1951 NW 7th Avenue Suite 520", "city": "Miami", "state": "FL", "zip": "33136", "country": "United States", "phone": "(305) 909-0840", "website": "https://longeveron.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, an allogeneic medicinal signaling cell therapy product isolated from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.", "fullTimeEmployees": 19, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joshua Michael Hare FACC, M.D.", "age": 59, "title": "Co-Founder, Chief Science Officer & Chairman", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 88000, "fmt": "88k", "longFmt": "88,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James  Clavijo CPA", "age": 56, "title": "CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 425358, "fmt": "425.36k", "longFmt": "425,358"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul T. Lehr J.D.", "age": 54, "title": "International Exec. Director, Gen. Counsel & Sec.", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 448259, "fmt": "448.26k", "longFmt": "448,259"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kwan-Hong  Min M.D., Ph.D.", "age": 55, "title": "Consultant", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 461359, "fmt": "461.36k", "longFmt": "461,359"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mohamed Wa'el Ahmed Hashad", "age": 59, "title": "Chief Exec. Officer", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Dan  Gincel Ph.D.", "age": 51, "title": "Sr. VP of Strategic Collaborations & Scientific Affairs", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}